Adam Bisaga is a Psychiatry physician affiliated with Columbia University. OpenAlex indexes 149 publications with 5,112 citations (h-index 43); ClinicalTrials.gov lists 14 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Evaluation of the O'Neil Long Acting Naltrexone Implant in Opioid Dependent Persons
Sponsor: Go Medical Industries Pty Ltd
Overall officialPhase 2Not, yet, recruitingNCT05382091 - Efficacy of Buprenorphine and XR-Naltrexone Combination for Relapse Prevention in Opioid Use Disorder
Sponsor: New York State Psychiatric Institute
Overall officialPhase 2/PHASE3RecruitingNCT05011266 - Pharmacokinetic Study of Vivitrol in Healthy Participants
Sponsor: Go Medical Industries Pty Ltd
Overall officialPhase 1CompletedNCT04716881
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
NIH funding
11 NIH research awards on record, funded 1999–2026 per NIH RePORTER. The latest:
- Efficacy of buprenorphine and XR-naltrexone combination for relapse prevention in opioid use disorder
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2026$695,203U01DA046430 - Evaluation of safety and pharmacokinetics of naltrexone implant
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2023$3,864,542UH3DA047720 - Efficacy of buprenorphine and XR-naltrexone combination for relapse prevention in opioid use disorder
New York State Psychiatric Institute Dba Research Foundation for Mental Hygiene, Inc
FY2023$686,136U01DA046430
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Serge Przedborski, MD, PhD
Columbia University
Shonni Silverberg, MD
Columbia University
Mitchell Benson, MD
Columbia University
Andrew Lassman, MD
Columbia University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”